Andere Sprachen Khiron Life Sciences Corp.

Aktien

A2JMZC

CA49374L3065

KHRN.H

Verzögert Toronto S.E. Andere Börsenplätze 16:54:46 05.05.2023			% 5 Tage	% 1. Jan.
0,04 ^CAD	-.--%		-.--%	-.--%

2023	Kolumbiens Cannabisindustrie in der Krise wegen regulatorischer und politischer Hürden	RE
2023	2518542 Alberta Ltd. hat die Übernahme von Khiron Europe Gmbh, Zerenia Clinics Limited, Khiron Life Sciences Spain SL, Khiron Life Sciences Uk und Pharmadrug Production GmbH von Khiron Life Sciences Corp. (TSXV:KHRN) abgeschlossen.	CI

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

Con inversores agotados, la industria de cannabis en Colombia se marchita sin acceso a mercado y zonas grises	21.12.
Colombia's cannabis industry in crisis over regulatory, political hurdles	21.12.
Khiron Life Sciences Announces Closing of the Sale of Its European Business	18.11.
Khiron Life Sciences Announces Update to the Proposed Sale of Its European Business	17.11.
2518542 Alberta Ltd completed the acquisition of Khiron Europe Gmbh, Zerenia Clinics Limited, Khiron Life Sciences Spain SL, Khiron Life Sciences Uk and Pharmadrug Production GmbH from Khiron Life Sciences Corp..	17.11.
2518542 Alberta Ltd agreed to acquire Khiron Europe Gmbh, Zerenia Clinics Limited, Khiron Life Sciences Spain SL, Khiron Life Sciences Uk and Pharmadrug Production GmbH from Khiron Life Sciences Corp. for CAD 3 million.	28.07.23
IIROC Trading Halt - KHRN	08.05.23
KHIRON LIFE SCIENCES ANNOUNCES CEASE TRADE ORDER	06.05.23
Khiron Life Sciences Corp. Enters into Partnership with an Accredited 3rd Party Contract Manufacturing Organization	20.04.23
Khiron Life Sciences Brief: On Filing of Audited Annual Financial Statements, Co Says Won't Make It On Or Before the Prescribed Deadline of May 1, 2023, as a Result of the Change in CFO	17.04.23
Khiron Life Sciences Brief: Appointing Michael O'Connor as Chief Financial Officer, Replacing Ms. Helen Bellwood	17.04.23
KHIRON LIFE SCIENCES ANNOUNCES NEW CFO	17.04.23
Khiron Life Sciences Announces CFO Changes	17.04.23
KHIRON LIFE SCIENCES ANNOUNCES SIZING OF MARKETED OFFERING OF UNITS	27.03.23
KHIRON LIFE SCIENCES ANNOUNCES PRICING OF MARKETED OFFERING OF UNITS	24.03.23
Toronto Stocks Climb; TerrAscend Rises on Plans to Apply for TSX Listing	14.03.23
Khiron Life Sciences Plans Overnight Marketed Offering of Share Units	13.03.23
KHIRON LIFE SCIENCES ANNOUNCES OVERNIGHT MARKETED OFFERING	13.03.23
Khiron Life Sciences Secures Additional Loan with Investment-Grade Bank	16.02.23
Khiron Life Sciences Corp. Announces That Its Wholly Owned Subsidiary Zerenia Colombia Closes an Unsecured Revolving Credit Facility of CAD 580,000 with Private Financing Company in Colombia	14.02.23

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen Khiron Life Sciences Corp.

Aktien

A2JMZC

CA49374L3065

KHRN.H

Andere Sprachen

Filter